Drug Type Monoclonal antibody |
Synonyms RLVT 9-01, RLVT-9-01 |
Target |
Mechanism MMP9 inhibitors(Matrix metalloproteinase 9 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Neuropathies | Preclinical | US | 28 Oct 2020 | |
Neuralgia | Preclinical | US | 28 Oct 2020 |